Emblok, Inc. — SEC Form D Filing
Emblok, Inc. filed an SEC Form D on June 18, 2026, reporting $6.00M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- June 18, 2026
- Amount reported
- $6.00M
- Industry
- Medical Devices
- Website
- https://emblok.com/
What the company does
Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Embolic debris can travel to vital organs like the brain, heart, kidneys, and intestines during left heart procedures, leading to risks such as stroke, heart damage, and kidney complications.
Solution
Emblok 360° is a whole-body embolic protection system designed to capture and remove embolic material during left heart (TAVR) procedures, protecting vital organs by blocking and capturing emboli before they can cause damage.
Verdict
Investors backed Emblok because it addressed a clearly defined, critical safety gap in a high-growth medical procedure, not because it promised a disruptive new therapeutic modality. Their implicit bet was on regulatory approval and rapid adoption within an existing clinical workflow. The upside was capped by its reliance on the sustained volume of TAVR procedures and the potential for competing, less invasive embolic protection methods to emerge, limiting market share and pricing power.
Source: SEC EDGAR Form D filing